Mineralocorticoid Blocker Gets EU Nod for Heart Failure
European regulators have moved to broaden the clinical use of Kerendia (finerenone, Bayer), backing its role in a…
Improving survival in people with severe psychiatric disorders
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
Study links obesity severity to escalating cardiometabolic and renal disease burden
Obesity severity is incrementally associated with a broad range of cardiometabolic and renal disease burden, as discovered by researchers at…